SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: DNLI) today announced initiation of dosing in a global Phase 2a clinical study, BEACON, of the investigational drug ...
Funding has been made available which will enable new research to take place into a possible link between manganese exposure ...
A team of international researchers led by Professor Johan Jakobsson at Lund University has secured a 52 million SEK grant from the Aligning Science ...
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the first patient has been dosed with exidavnemab in the EXIST Phase 2a study, in Parkinson's disease patients. Exidavnemab is a ...
Director of public prosecutions Stephen Parkinson sets out plan to tackle crisis as massive rise in rape victim ‘attrition ...
Sleep fragmentation is a prevalent issue in Parkinson’s disease, significantly impacting quality of life and disease ...
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.
The Killeen Police Department is investigating a shooting that left two people injured.Officers are currently conducting the ...